An Observational Study of Patients With Chronic Liver Disease

Part of paid clinical trials in Los Angeles, California.

Sponsor
Target PharmaSolutions, Inc.
Study ID
NCT05744713
Status
Enrolling By Invitation

Conditions

  • Chronic Liver Disease
  • Cirrhosis

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Observational — OTHER
    Observational

Study Details

TARGET-Liver Disease (TARGET-LD) is an observational research study to conduct a comprehensive review of outcomes for patients with chronic liver disease (CLD).

Key Dates

Start date
Feb 19, 2024
Status verified
Mar 2026
Primary completion
Dec 31, 2037
Completion
Dec 31, 2037

Study Design

Enrollment
500,000 participants (estimated)

Arms

  • Arm: Disease Cohort
  • Arm: Engaged Cohort

Primary Outcome Measure

To characterize the natural history of disease in patients with CLD from various etiologies and Cirrhosis [ Time Frame: 20 Years ]

Locations (10)

FacilityCityStateZIPSite coordinators
Keck School of Medicine of USCLos AngelesCalifornia90033-
Stanford MedicineRedwood CityCalifornia94063-
Georgetown Medstar Transplant InstituteWashington D.C.District of Columbia20007-
Rush University Medical CenterChicagoIllinois60612-
Columbia University Irving Medical Center/ New York Presbyterian HospitalNew YorkNew York10032-
Atrium Health Center for Liver Disease and TransplantCharlotteNorth Carolina28204-
Temple University - Lewis Katz School of MedicinePhiladelphiaPennsylvania19140-
University of PennsylvaniaPhiladelphiaPennsylvania19104-
Baylor Scott & White Research InstituteDallasTexas75246-
Baylor College of MedicineHoustonTexas77021-

Find similar trials in Los Angeles, CA

By research site
Keck School of Medicine of USC· Los Angeles, CAStanford Medicine· Redwood City, CAGeorgetown Medstar Transplant Institute· Washington D.C., DCRush University Medical Center· Chicago, ILColumbia University Irving Medical Center/ New York Presbyterian Hospital· New York, NYAtrium Health Center for Liver Disease and Transplant· Charlotte, NC

Related Studies